Detalhe da pesquisa
1.
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trial.
EClinicalMedicine
; 71: 102582, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38618202